Cronos (CRON) Raw Materials (2016 - 2019)
Cronos (CRON) posted quarterly Raw Materials of $995000.0 for Q4 2019, up 668.03% year-over-year from $129553.0 in Q4 2018, and up 668.03% quarter-over-quarter from $129553.0 in Q4 2018.
Cronos (CRON) Raw Materials (2016 - 2019) Analysis & Trends
Cronos' Raw Materials history runs 4 years deep, the most recent figure standing at $995000.0 for Q4 2019.
- In Q4 2019, Raw Materials rose 668.03% year-over-year to $995000.0; the TTM figure through Dec 2019 stood at $995000.0 (up 668.03% YoY), while the FY2019 annual figure was $995000.0, up 69.22% from the prior year.
- Raw Materials for Q4 2019 stood at $995000.0, up from $129553.0 in the prior quarter.
- The five-year high for Raw Materials was $995000.0 in Q4 2019, with the low at $129553.0 in Q4 2018.
- The 4-year median for Raw Materials is $144743.9 (2017), against an average of $353510.2.
- The sharpest annual moves came in 2018 and 2019: Raw Materials fell 10.06% in 2018, then surged 668.03% in 2019.
- Cronos' Raw Materials stood at $145440.8 in 2016, then decreased by 0.96% to $144047.0 in 2017, then dropped by 10.06% to $129553.0 in 2018, then surged by 668.03% to $995000.0 in 2019.
- Business Quant data shows CRON's Raw Materials at $995000.0 in Q4 2019, $129553.0 in Q4 2018, and $144047.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 995,000.00 |
| Dec 31, 2018 | 129,552.98 |
| Dec 31, 2017 | 144,047.03 |
| Dec 31, 2016 | 145,440.79 |